Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D | P25100 | 17/20 | 0.80 |
| ▸ | ADRA1A | P35348 | 17/20 | 0.80 |
| ▸ | ADRA1B | P35368 | 17/20 | 0.80 |
| ▸ | DRD2 | P14416 | 1/20 | 0.51 |
| ▸ | DRD4 | P21917 | 1/20 | 0.51 |
| ▸ | DRD5 | P21918 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8670258 | 0.91 | ADRA1D (0.66) | ADRA1DADRA1AADRA1B | |
| SCHEMBL8666853 | 0.89 | ADRA1D (1.00) | ADRA1DADRA1AADRA1BDRD2DRD4 | |
| SCHEMBL8672562 | 0.89 | ADRA1D (1.00) | ADRA1DADRA1AADRA1BDRD2DRD4 | |
| SCHEMBL8667634 | 0.89 | ADRA1D (0.82) | ADRA1DADRA1AADRA1BDRD2DRD4 | |
| SCHEMBL8672467 | 0.86 | ADRA1D (0.80) | ADRA1DADRA1AADRA1BDRD2DRD4 | |
| SCHEMBL8669051 | 0.85 | ADRA1D (0.78) | ADRA1DADRA1AADRA1BDRD2DRD4 | |
| SCHEMBL8814007 | 0.84 | ADRA1D (1.00) | ADRA1DADRA1AADRA1B | |
| SCHEMBL8667587 | 0.84 | ADRA1D (0.88) | ADRA1DADRA1AADRA1BDRD2DRD4 | |
| SCHEMBL8674154 | 0.83 | ADRA1D (1.00) | ADRA1DADRA1AADRA1BDRD2DRD4 | |
| SCHEMBL8670191 | 0.83 | ADRA1D (1.00) | ADRA1DADRA1AADRA1BDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5760054-A | BENIGN PROSTATIC HYPERTROPHY | MERCK & CO., INC. (US) | 1998-06-02 | — | — | US | disclosed |
| EP-0755392-A4 | ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS | MERCK & CO INC (US) | 1997-05-02 | — | — | EP | disclosed |
| EP-0755392-A1 | ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS | MERCK & CO. INC. (US) | 1997-01-29 | — | — | EP | disclosed |
| WO-1995028397-A1 | ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1995-10-26 | — | — | WO | disclosed |